86 related articles for article (PubMed ID: 24199880)
1. [Blood pressure control and glucose metabolism status in hypertension specialty clinics in China].
Sun NL; Wang HY; Huo Y
Zhonghua Nei Ke Za Zhi; 2013 Aug; 52(8):654-8. PubMed ID: 24199880
[TBL] [Abstract][Full Text] [Related]
2. [National survey of blood pressure control rate in Chinese hypertensive outpatients-China STATUS].
Hu DY; Liu LS; Yu JM; Yao CH;
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Mar; 38(3):230-8. PubMed ID: 20450565
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.
Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K;
Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115
[TBL] [Abstract][Full Text] [Related]
4. [A cross-sectional study on the treatment goals of blood pressure, serum lipids and blood glucose in elderly patients with coronary heart disease].
Zhu Y; Wang J; Bao Y; Qiao YX; Wu LZ; Li J; Li J; Hu DY
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(21):1479-85. PubMed ID: 21914285
[TBL] [Abstract][Full Text] [Related]
5. [Reasons for not intensifying antihypertensive treatment to diabetes in some regions of China].
Guo QH; Pan CY; Qi WH; Lin SY;
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):240-4. PubMed ID: 18361834
[TBL] [Abstract][Full Text] [Related]
6. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hypertension, control of blood pressure and treatment in hypertensive with type 2 diabetes in Hospital University Sains Malaysia.
Abougalambou SS; Abougalambou AS; Sulaiman SA; Hassali MA
Diabetes Metab Syndr; 2011; 5(3):115-9. PubMed ID: 22813562
[TBL] [Abstract][Full Text] [Related]
8. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
9. [A survey of factors influencing prognosis and control rate for patients with hypertension in mainland China].
Qi WH; Pan CY; Lin SY
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 May; 35(5):457-60. PubMed ID: 17711690
[TBL] [Abstract][Full Text] [Related]
10. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.
UK Prospective Diabetes Study Group
BMJ; 1998 Sep; 317(7160):703-13. PubMed ID: 9732337
[TBL] [Abstract][Full Text] [Related]
11. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
[TBL] [Abstract][Full Text] [Related]
12. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
Luque Otero M; Martell Claros N;
Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
[TBL] [Abstract][Full Text] [Related]
13. [A multi-center survey of hypertension and its treatment in patients with maintenance hemodialysis in Shanghai].
Lin J; Ding XQ; Lin P; Zou JZ; Teng J; Zhang JY; Wang NS; Zhou FJ; Shen PC; He LQ; Bao XR; Xu SR; Yang H; Zhang JH; Zhu KY; Li XH; Jiang GR; Zhang W
Zhonghua Nei Ke Za Zhi; 2010 Jul; 49(7):563-7. PubMed ID: 20979764
[TBL] [Abstract][Full Text] [Related]
14. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
15. [Clustering of cardiovascular risk factors and hypertension control status among hypertensive patients in the outpatient setting].
Liu J; Wang W; Liu J; Qi Y; Sun JY; Zhao D
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Dec; 41(12):1050-4. PubMed ID: 24524610
[TBL] [Abstract][Full Text] [Related]
16. Amlodipine versus angiotensin II receptor blocker; control of blood pressure evaluation trial in diabetics (ADVANCED-J).
Kawamori R; Daida H; Tanaka Y; Miyauchi K; Kitagawa A; Hayashi D; Kishimoto J; Ikeda S; Imai Y; Yamazaki T
BMC Cardiovasc Disord; 2006 Oct; 6():39. PubMed ID: 17029631
[TBL] [Abstract][Full Text] [Related]
17. Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors.
Aksnes TA; Reims HM; Guptha S; Moan A; Os I; Kjeldsen SE
J Hum Hypertens; 2006 Nov; 20(11):860-6. PubMed ID: 16988754
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
19. Gap between evidence and physicians' knowledge and practice regarding hypertension and its drug treatment: a survey in a Chinese city.
Wang WZ; Tang JL; Hu YH; An JG; Wang YL; Ren ZH; Zhang H; Griffiths S
Chin Med J (Engl); 2011 Apr; 124(8):1235-41. PubMed ID: 21543003
[TBL] [Abstract][Full Text] [Related]
20. [Hypertension management in general practice in Iceland].
Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
